Brazilian Pharmaceuticals 2026: The Innovation & Patent Cliff Frontier<\/a>
<\/p>\n\n\n\n<\/p>","protected":false},"excerpt":{"rendered":"
As of early 2026, Brazil has solidified its position as the largest pharmaceutical market in Latin America. Industry data highlights a “transition from defensive to offensive” strategies, where local companies are using AI and digital health tools as core infrastructure for drug discovery and supply chain management to navigate a high-stakes, rationalized market. Read more: […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[],"class_list":["post-1","post","type-post","status-publish","format-standard","hentry","category-pharma"],"_links":{"self":[{"href":"https:\/\/biointell.lat\/pt\/wp-json\/wp\/v2\/posts\/1","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biointell.lat\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biointell.lat\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biointell.lat\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/biointell.lat\/pt\/wp-json\/wp\/v2\/comments?post=1"}],"version-history":[{"count":1,"href":"https:\/\/biointell.lat\/pt\/wp-json\/wp\/v2\/posts\/1\/revisions"}],"predecessor-version":[{"id":471,"href":"https:\/\/biointell.lat\/pt\/wp-json\/wp\/v2\/posts\/1\/revisions\/471"}],"wp:attachment":[{"href":"https:\/\/biointell.lat\/pt\/wp-json\/wp\/v2\/media?parent=1"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biointell.lat\/pt\/wp-json\/wp\/v2\/categories?post=1"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biointell.lat\/pt\/wp-json\/wp\/v2\/tags?post=1"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}